Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


04.09.2017

1 Abdom Radiol (NY)
1 Acta Oncol
1 AJR Am J Roentgenol
1 Am J Cancer Res
5 BJU Int
2 Cancer
1 Cancer Prev Res (Phila)
1 Cell Physiol Biochem
3 Clin Genitourin Cancer
1 Hum Pathol
1 J Endourol
1 J Toxicol Environ Health A
3 J Urol
1 Mol Oncol
1 Onco Targets Ther
1 Oncol Rep
1 Pathol Res Pract
1 Sci Rep
1 Ther Clin Risk Manag
1 Turk J Urol
1 Urologiia
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Abdom Radiol (NY)

  1. GOTTLIEB J, Princenthal R, Cohen MI
    Multi-parametric MRI findings of granulomatous prostatitis developing after intravesical bacillus calmette-guerin therapy.
    Abdom Radiol (NY). 2017;42:1963-1967.
    PubMed     Text format     Abstract available


    Acta Oncol

  2. BOUSTANI J, Bertaut A, Galsky MD, Rosenberg JE, et al
    Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
    Acta Oncol. 2017 Aug 30:1-7. doi: 10.1080/0284186X.2017.1369565.
    PubMed     Text format     Abstract available


    AJR Am J Roentgenol

  3. LEE CH, Tan CH, Faria SC, Kundra V, et al
    Role of Imaging in the Local Staging of Urothelial Carcinoma of the Bladder.
    AJR Am J Roentgenol. 2017 Feb 22:1-13. doi: 10.2214/AJR.16.17114.
    PubMed     Text format     Abstract available


    Am J Cancer Res

  4. YANG X, Shi L, Yi C, Yang Y, et al
    MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1.
    Am J Cancer Res. 2017;7:1738-1753.
    PubMed     Text format     Abstract available


    BJU Int

  5. CHAPPIDI MR, Kates M, Tosoian JJ, Johnson MH, et al
    Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.
    BJU Int. 2017;120:377-386.
    PubMed     Text format     Abstract available

  6. BLUTE ML JR, Kucherov V, Rushmer TJ, Damodaran S, et al
    Reduced estimated glomerular filtration rate (eGFR <60 mL/min/1.73 m2 ) at first transurethral resection of bladder tumour is a significant predictor of subsequent recurrence and progression.
    BJU Int. 2017;120:387-393.
    PubMed     Text format     Abstract available

  7. BAILEY GC, Boorjian SA, Ziegelmann MJ, Westerman ME, et al
    Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.
    BJU Int. 2017;119:585-590.
    PubMed     Text format     Abstract available

  8. MARCHIONI M, Primiceri G, Cindolo L, Hampton LJ, et al
    Impact of diagnostic ureteroscopy on intravesical recurrence in patients undergoing radical nephroureterectomy for upper tract urothelial cancer: a systematic review and meta-analysis.
    BJU Int. 2017;120:313-319.
    PubMed     Text format     Abstract available

  9. HINATA N, Hussein AA, George S, Trump DL, et al
    Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study.
    BJU Int. 2017;119:605-611.
    PubMed     Text format     Abstract available


    Cancer

  10. SCOTT SN, Ostrovnaya I, Lin CM, Bouvier N, et al
    Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guerin.
    Cancer. 2017;125:416-426.
    PubMed     Text format     Abstract available

  11. KOPP RP, Stratton KL, Glogowski E, Schrader KA, et al
    Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma.
    Cancer. 2017;123:2452-2458.
    PubMed     Text format     Abstract available


    Cancer Prev Res (Phila)

  12. JIN F, Thaiparambil J, Donepudi SR, Vantaku VR, et al
    Tobacco-specific carcinogens induce hypermethylation, DNA adducts and DNA damage in Bladder Cancer.
    Cancer Prev Res (Phila). 2017 Aug 29. pii: canprevres.0198.2017.
    PubMed     Text format     Abstract available


    Cell Physiol Biochem

  13. WOJTCZYK-MIASKOWSKA A, Presler M, Michajlowski J, Matuszewski M, et al
    Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer.
    Cell Physiol Biochem. 2017;42:2404-2417.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  14. ABUFARAJ M, Haitel A, Moschini M, Gust K, et al
    Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2017 Aug 15. pii: S1558-7673(17)30198.
    PubMed     Text format     Abstract available

  15. ABDEL-RAHMAN O
    Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Clin Genitourin Cancer. 2017 Aug 3. pii: S1558-7673(17)30235.
    PubMed     Text format     Abstract available

  16. PARKER WP, Smelser W, Lee EK, Habermann EB, et al
    Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients.
    Clin Genitourin Cancer. 2017 Aug 1. pii: S1558-7673(17)30208.
    PubMed     Text format     Abstract available


    Hum Pathol

  17. SHAH TS, Kaag M, Raman JD, Chan W, et al
    Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
    Hum Pathol. 2017;61:90-96.
    PubMed     Text format     Abstract available


    J Endourol

  18. PAN S, Smith AD, Motamedinia P
    Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer.
    J Endourol. 2017;31:238-245.
    PubMed     Text format     Abstract available


    J Toxicol Environ Health A

  19. KUHN C, Lehmann ML, Kress A, Truss MC, et al
    Micro-brushing-based technique to gain fresh urothelial cells for gene expression analysis.
    J Toxicol Environ Health A. 2017;80.
    PubMed     Text format     Abstract available


    J Urol

  20. SMITH ZL, Johnson SC, Golan S, McGinnis JR, et al
    Fistulous complications following radical cystectomy for bladder cancer: analysis of a large modern cohort.
    J Urol. 2017 Aug 28. pii: S0022-5347(17)77409-5. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  21. HURLE R, Lazzeri M, Vanni E, Lughezzani G, et al
    Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): a confirmatory and resource consumption study from Bladder cancer Italian Active Surveillance (BIAS) project.
    J Urol. 2017 Aug 25. pii: S0022-5347(17)77391-0. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available

  22. NARAYAN VM, Adejoro O, Schwartz I, Ziegelmann M, et al
    The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer.
    J Urol. 2017 Aug 28. pii: S0022-5347(17)77411-3. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    Mol Oncol

  23. HUANG H, Jin H, Zhao H, Wang J, et al
    RhoGDIbeta Promotes Sp1/MMP-2 Expression and Bladder Cancer Invasion Through Perturbing miR-200c-Targeted JNK2 Protein Translation.
    Mol Oncol. 2017 Aug 28. doi: 10.1002/1878-0261.12132.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  24. SUN M, Zhao W, Zeng Y, Zhang D, et al
    Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target.
    Onco Targets Ther. 2017;10:3949-3956.
    PubMed     Text format     Abstract available


    Oncol Rep

  25. TSUJITA Y, Horiguchi A, Tasaki S, Isono M, et al
    STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
    Oncol Rep. 2017 Aug 11. doi: 10.3892/or.2017.5902.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  26. HE X, Ding X, Wen D, Hou J, et al
    Exploration of the pathways and interaction network involved in bladder cancer cell line with knockdown of Opa interacting protein 5.
    Pathol Res Pract. 2017 Aug 1. pii: S0344-0338(17)30130.
    PubMed     Text format     Abstract available


    Sci Rep

  27. VERMA N, Pink M, Boland S, Rettenmeier AW, et al
    Benzo[a]pyrene-induced metabolic shift from glycolysis to pentose phosphate pathway in the human bladder cancer cell line RT4.
    Sci Rep. 2017;7:9773.
    PubMed     Text format     Abstract available


    Ther Clin Risk Manag

  28. CHENG B, Qiu X, Li H, Yang G, et al
    The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer.
    Ther Clin Risk Manag. 2017;13:983-988.
    PubMed     Text format     Abstract available


    Turk J Urol

  29. KUS T, Aktas G
    Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival.
    Turk J Urol. 2017;43:273-278.
    PubMed     Text format     Abstract available


    Urologiia

  30. LORAN OB, Sinyakova LA, Gundorova LV, Kosov VA, et al
    [High oncogenic risk human papillomavirus and urinary bladder cancer].
    Urologiia. 2017;:60-66.
    PubMed     Text format     Abstract available


    Urology

  31. WILLIAMS SB, Huo J, Chu Y, Baillargeon JG, et al
    Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making.
    Urology. 2017 Aug 25. pii: S0090-4295(17)30886.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: